Zobrazeno 1 - 6
of 6
pro vyhledávání: '"I. E. Mikhailova"'
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 1S (2024)
Aim. To find out the relationship between the awareness level of clinical guidelines on heart failure (HF) with reduced ejection fraction and a number of professional characteristics (specialty, work experience, self-assessment of awareness level, at
Externí odkaz:
https://doaj.org/article/db3be8163a634d86a3fc5c142decf2ef
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 5, Pp 706-712 (2020)
Aim. To study doctors’ knowledge of the clinical guidelines on the use of oral anticoagulants and identify the reasons for poor adherence.Material and methods. The results of the 218 questionnaires completed by the doctors trained in the 2018-2019
Externí odkaz:
https://doaj.org/article/6732786f87f34494a4e31962ffc5e9ef
Autor:
N. B. Perepech, I. E. Mikhailova
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 2S (2021)
The review is devoted to the clinical efficacy of sodium-glucose cotransporter type 2 (SGLT2) inhibitors. Information on the mechanisms of drug action is given, as well as rationale for their use in the management of patients with diabetes and heart
Externí odkaz:
https://doaj.org/article/fe3f026a31e64973b029521f97d0b813
Publikováno v:
Kardiologiia. 62:53-61
Aim To evaluate the physician’s knowledge of basic provisions of clinical guidelines for diagnosis and treatment of chronic heart failure (CHF) and to determine how the actions of physicians in their everyday clinical practice comply with these pro
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 5, Pp 706-712 (2020)
Aim. To study doctors’ knowledge of the clinical guidelines on the use of oral anticoagulants and identify the reasons for poor adherence.Material and methods. The results of the 218 questionnaires completed by the doctors trained in the 2018-2019
Autor:
I. E. Mikhailova, N. B. Perepech
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 2S (2021)
The review is devoted to the clinical efficacy of sodium-glucose cotransporter type 2 (SGLT2) inhibitors. Information on the mechanisms of drug action is given, as well as rationale for their use in the management of patients with diabetes and heart